Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLS | AMGN | GILD | CELG | VRTX |
| Company | Sellas Life Sciences Group Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.3200 | 266.83 | 67.80 | 108.01 | 396.88 |
| High | 1.3600 | 267.51 | 67.89 | 108.59 | 398.49 |
| Low | 1.2800 | 263.81 | 67.19 | 107.27 | 393.51 |
| Last | 1.3600 | 264.70 | 67.51 | 108.24 | 394.18 |
| Change | +0.0300 | -0.81 | -0.24 | +0.11 | -3.18 |
| % Change | +2.26% | -0.31% | -0.35% | +0.10% | -0.80% |
| Volume | 622,296 | 748,693 | 1,933,395 | 191,230,496 | 240,290 |
| 20-Day Average Volume | 1,705,769 | 2,204,585 | 6,272,989 | 16,188,930 | 876,902 |
| Previous Close | 1.3300 | 265.51 | 67.75 | 108.13 | 397.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2080 | 273.83 | 70.94 | 108.17 | 408.64 |
| 20-Day Raw Stochastic | 74.53% | 4.25% | 5.63% | 63.25% | 3.80% |
| 20-Day Relative Strength | 59.98% | 38.30% | 31.27% | 64.69% | 37.36% |
| Weighted Alpha | +27.50 | +5.50 | -23.02 | +46.30 | +16.07 |
| Today's Opinion | 72% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Last Month's Opinion | 8% Sell | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.21% since 04/09/24 | -1.98% since 04/09/24 | -3.37% since 04/09/24 | -1.97% since 11/13/19 | -2.45% since 04/09/24 |
| Low | 1.2700 on 04/15/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 107.27 on 11/20/19 | 393.53 on 04/16/24 |
| High | 1.4800 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 110.53 on 11/14/19 | 404.69 on 04/11/24 |
| 1-Month | |||||
| %Chg | +23.18% since 03/15/24 | -1.44% since 03/15/24 | -8.29% since 03/15/24 | +5.14% since 10/18/19 | -3.21% since 03/15/24 |
| Low | 0.9600 on 03/26/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 102.40 on 10/21/19 | 393.53 on 04/16/24 |
| High | 1.4900 on 04/08/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +158.10% since 01/16/24 | -12.68% since 01/16/24 | -21.41% since 01/16/24 | +13.63% since 08/20/19 | -9.81% since 01/16/24 |
| Low | 0.4986 on 01/26/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 93.41 on 08/23/19 | 393.53 on 04/16/24 |
| High | 1.7200 on 03/14/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +6.69% since 10/16/23 | -7.63% since 10/16/23 | -14.67% since 10/16/23 | +14.14% since 05/20/19 | +5.51% since 10/16/23 |
| Low | 0.4986 on 01/26/24 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 1.7200 on 03/14/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 74,836 | 142,291,856 | 84,353,968 | 77,035,920 | 102,701,272 |
| Shares Outstanding, K | 56,268 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -37,340,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -8,140,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 2.35 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 03/28/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 10.99 | 29.51 |